The Vanderbilt-Ingram Cancer Center Department of Pharmacy Specialty Oncology Residency is a 12-month program. The graduate will obtain the specialized oncology knowledge base and clinical skills required to become competent in the pharmaceutical care of cancer patients. We are an accredited residency program by ASHP and follow their guidelines and vision closely. The resident will have opportunities in all aspects of oncology pharmacy practice related to clinical practice and outcomes, short-term research projects, and educating other health care professionals.
Blood & Marrow Transplantation
Investigational Drug Services
All rotations are four weeks in duration. One 4-week block will be designated as a transitional period dedicated to project time and meeting attendance and another 4-week block for orientation. The resident schedule is flexible in order to allow the resident to meet his/her career goals and interests.
|Benefits||2013 - 2014 Oncology Resident|
|TN Board of Pharmacy & NABP||Preceptors|
|Vanderbilt Community||Nashville, Tennessee|
Applicant must be a graduate of an accredited Doctor of Pharmacy program, be a licensed pharmacist in any state with reciprocation to Tennessee and completed an accredited PGY1 residency program.
The Pharmacy Residency program is open to all US citizens, US nationals and eligible noncitizens. Information on US nationals and eligible noncitizens can be found on Vanderbilt’s “US National and Eligible Non-Citizens” page. Immigration sponsorship is not offered, so persons needing immigration sponsorship to work in the USA cannot be accepted into the program.
Submit the following application materials for Oncology Residency to be received by January 1.
Number of Positions: One
Application Requirements: Doctor of Pharmacy degree,
PGY1 pharmacy residency certificate, licensure in Tennessee
Application Deadline: January 1
PhORCAS application portal
Starting Date: July 1
Mahsa S. Talbott, PharmD, BCOP, Program Director
|Estimated stipend - approx. $60,593*
1 position available
* info has not been verified